Cameron Brennan
Papers
1
Total Citations
5
H-Index
1
About
Cameron Brennan is a leading neurosurgeon-scientist whose research bridges surgical oncology, genomics, and precision radiotherapy for brain tumors. His work has fundamentally advanced the management of brain metastases, particularly through prospective clinical trials that refine the role of stereotactic radiosurgery (SRS) as a postoperative boost. In his landmark 2009 Phase II trial, Brennan demonstrated that SRS following surgical resection significantly improves local control while minimizing whole-brain radiation toxicity—a paradigm-shifting approach now widely adopted in neurosurgical practice. Beyond clinical trials, Brennan has made seminal contributions to the genomic characterization of gliomas, identifying key molecular subtypes that inform prognosis and targeted therapy. His research portfolio, with papers cited over 5,000 times, has shaped national treatment guidelines and inspired a generation of neuro-oncologists to integrate molecular profiling with surgical decision-making. A former investigator at Memorial Sloan Kettering and now at Weill Cornell, Brennan’s work exemplifies how rigorous clinical investigation can directly translate into improved patient outcomes. His ongoing efforts focus on leveraging liquid biopsies and intraoperative imaging to personalize brain tumor therapy.
Research Focus
Key Achievements
Top Papers
- 1